IP Pragmatics is carrying out a survey on behalf of The European Bank for induced pluripotent Stem Cells (EBiSC) into the use of induced pluripotent stem cell (iPSC) lines in research to improve products and services offered.
EBiSC is a centralised, not-for-profit, iPSC bank providing academic and industry researchers worldwide with access to scalable, cost-efficient and consistent, high quality tools for new medicines development and disease modelling.
If you work with iPSCs, or know of others who work with iPSCs, and can spare a few minutes of your time, you can access the survey here. Respondents can also enter a prize draw to win a free cell line of your choice from the EBiSC catalogue.
If you would like to know more about EBiSC and its current iPSC catalogue, please visit: http://www.ebisc.org/